{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 1,
  "pageCount": 239,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "cover",
  "function": "front_matter",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Includes a YouTube link referencing the film 'Spinal Tap' as a metaphor for the company's technology.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/7dXsNe68Vhvy79-YCgI8aKhcK5dUbuEny_srKRZwB_k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5wbmc",
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/1",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-1",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b336-60c6d60dfdf2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.66,
        "x": 0.17,
        "y": 0.525
      },
      "kind": "image",
      "text": "Spinal Tap, the fictitious 1980's rock band and Nevro parable, explains the science behind the company's “high frequency“ spinal cord stimulator.",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "862b65fd-41d4-4809-9fad-dad11c2a7e88",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "market cap: $5.8B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b336-68e10babe77a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.78,
        "x": 0.11,
        "y": 0.475
      },
      "kind": "paragraph",
      "text": "$5.8B market cap | $168/share | $65/$188 52wk hi/low | $51M ADV, 30d avg | Short interest 8% of float",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60e01451-c8cc-4105-aa00-7acc33f61af1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Spinal Tap, the fictitious 1980’s rock band and Nevro parable, explains the science behind the company’s “high frequency“ spinal cord stimulator.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b336-64456a0d2915",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.26
      },
      "kind": "title",
      "text": "A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b6f4469-a40f-4997-abaa-a5a20ad96a44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.25,
        "y": 0.175
      },
      "kind": "title",
      "text": "NEVRO (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02aa708e-9597-4cb6-a634-1c3259cfe976",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54522dc3-5464-43ca-a814-20c7945b33a6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "bc4ef4ad-28ba-41d1-9840-9f2c616db5ab",
      "evidence": "The slide provides information about Nevro, including its market cap, stock price, and short interest, indicating that the audience is likely investors or financial analysts.",
      "confidence": 0.7
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "0c88baf8-f7ca-4e5d-ae6d-2c5fbcb89e5f",
      "evidence": "The title/action-title 'A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall' could be seen as a call to action, although it's more of a provocative statement.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "3ace5aba-830c-40c8-9961-c870acd53807",
      "evidence": "The slide frames the company as a 'failed one-trick pony' and 'reeking of fraud'.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/RC3JM2aUc62nkklJrAln2fgUPEcsBKcXNX9CDPqkWS0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5qcGc",
  "thumbSrc": "https://imgproxy.kitesheet.com/11lFtRukJfA8csh2hzU8U_KRV0RWLauHyaHiO5Abq9c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5wbmc",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/BhxUolGWlle-8ScycKQLXTCIH5naDH2megG4KnxPxgA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5qcGc"
}